Learnings from Patient Mortality after Delandistrogene Moxeparvovec Administration: A Report of Two Cases and Expert Committee Considerations for Future Mitigation and Management.
Saved in:
| Title: | Learnings from Patient Mortality after Delandistrogene Moxeparvovec Administration: A Report of Two Cases and Expert Committee Considerations for Future Mitigation and Management. |
|---|---|
| Authors: | Shieh, Perry B.1 (AUTHOR), Proud, Crystal2 (AUTHOR), Diamond, Tamir3 (AUTHOR), Chapin, Catherine A.4 (AUTHOR), Ahmad, Jawad5 (AUTHOR), Salama, Alan D.6 (AUTHOR), Bönnemann, Carsten G.7 (AUTHOR), Soslow, Jonathan8 (AUTHOR), Byrne, Barry J.9 (AUTHOR), Veerapandiyan, Aravindhan10 (AUTHOR), Brandsema, John F.3 (AUTHOR), Matesanz, Susan3 (AUTHOR), Samelson-Jones, Benjamin J.3 (AUTHOR), Wilkins, Benjamin J.3 (AUTHOR), Gerber, Marianne11 (AUTHOR), Godwin Wild, Kara E.12 (AUTHOR), Mason, Stefanie12 (AUTHOR), Asher, Damon12 (AUTHOR), McDonald, Craig M.13 (AUTHOR), Mendell, Jerry R.12 (AUTHOR) JMendell@sarepta.com |
| Source: | Human Gene Therapy. Mar2026, Vol. 37 Issue 5/6, p262-279. 18p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
